Investor advisors are all professional investors with proven track records in building value with technology and biotechnology teams. While only a part of the
With no obligation to “do business” with one another, Yale entrepreneurs and our ingestor advisors interact primarily when teams are beginning to formulate a capital raise strategy. This provides our innovators with a chance to test their more detailed plans, as well as an opportunity for our investor advisors to keep abreast of cutting edge science and potentially disruptive products and services.
Dr. Stephen Bloch